Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for healing of intertrochanteric fractures after gamma nail surgery
IRCT20201121049452N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of teriparatide in intertrochanteric fracture (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Duration of repair of intertrochanteric fracture from the time of surgery. Started Jan 2019; status: completed.
02
Drugs
teriparatide
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on IRCT20201121049452N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201121049452N1.